Sunnybrook Hospital

Futó vizsgálatok

• Toboroz

  A Post Authorization Registry Study of Participants Treated With LEQEMBI

  NCT07762092· Eisai Limited· Forrás

• Toboroz

  Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing

  NCT07387263· Unity Health Toronto· Forrás

• Toboroz

  The Genetics Navigator: Evaluating a Digital Platform for Genomics Health Services

  NCT06455384· Unity Health Toronto· Forrás

• Toboroz

  The Dragon PLC Trial (DRAGON-PLC)

  NCT06914648· Maastricht University· Forrás

• Toboroz

  Reversal of Atrial Substrate to Prevent Atrial Fibrillation Cohort Study

  NCT06249269· Ratika Parkash· Forrás

• Toboroz

  Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock

  NCT05298124· Ottawa Heart Institute Research Corporation· Forrás

• Fut, nem toboroz

  Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.

  NCT05270044· 3. fázis· Pierre Fabre Medicament· Forrás

• Toboroz

  The DRAGON 2 Trial

  NCT05428735· Maastricht University· Forrás

• Fut, nem toboroz

  A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

  NCT04974398· 3. fázis· Akeso· Forrás

• Toboroz

  Statins for Venous Event Reduction in Patients With Venous Thromboembolism

  NCT04319627· 3. fázis· Ottawa Hospital Research Institute· Forrás

• Toboroz

  Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

  NCT04634240· University of British Columbia· Forrás

• Toboroz

  Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

  NCT04045665· 3. fázis· Icahn School of Medicine at Mount Sinai· Forrás

• Fut, nem toboroz

  Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas

  NCT02503423· 1/2. fázis· Taiho Oncology, Inc.· Forrás

• Toboroz

  Nephrotic Syndrome Study Network

  NCT01209000· University of Michigan· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Máj- és epeúti rák2 toboroz
• Pitvarfibrilláció2 toboroz
• Vastagbélrák2 toboroz
• Alzheimer-kór1 toboroz
• Aortic stenosis1 toboroz
• Deep vein thrombosis and pulmonary embolism1 toboroz
• Epilepszia1 toboroz
• Hasnyálmirigyrák1 toboroz
• Koszorúér-betegség1 toboroz
• Nephrotic syndrome1 toboroz
• Petefészekrák1 toboroz
• Prosztatarák1 toboroz
• Stroke (szélütés)1 toboroz

Lezárt vizsgálatok

• Lezárult

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  RAFF4 Trial: Vernakalant vs. Procainamide for Acute Atrial Fibrillation in the Emergency Department

  NCT04485195· 4. fázis· Ottawa Hospital Research Institute· Forrás

• Leállították

  A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205

  NCT04241068· 3. fázis· Biogen· Forrás

• Lezárult

  Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]

  NCT03734029· 3. fázis· Daiichi Sankyo· Forrás

• Lezárult

  DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]

  NCT03529110· 3. fázis· Daiichi Sankyo· Forrás

• Lezárult

  Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation

  NCT01938248· 4. fázis· Population Health Research Institute· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Mild cognitive impairment23 munka · 0 vizsgálat